S. Chaffee

Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors.

David P. Carney, P. Gallant, M. Morrison, 2011, Bioorganic & medicinal chemistry letters.

Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation.

P. Gallant, A. Oliveira-dos-Santos, J. Newcomb, 2008, Journal of medicinal chemistry.

Pneumonia due to Fonsecaea pedrosoi and cerebral abscesses due to Emericella nidulans in a bone marrow transplant recipient.

J. Perfect, W. Schell, A. Morris, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficient construction of the securine A carbon skeleton.

J. Shotwell, S. Chaffee, P. Korakas, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitors.

P. Gallant, M. Morrison, P. Rose, 2007, Bioorganic & medicinal chemistry letters.

Improved Synthesis of [Mn(CO)5OClO3], a Versatile Reagent for the Preparation of Cationic (Polyene)manganese(I) Complexes. Crystal Structure of [(η4-1,5-Cyclooctadiene)Mn(CO)4]ClO4

Jonathan T. Maeyer, R. Pike, G. Carpenter, 1998 .

Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor.

Richard Kendall, P. Gallant, M. Morrison, 2007, Journal of medicinal chemistry.

Alkynylpyrimidine amide derivatives as potent, selective, and orally active inhibitors of Tie-2 kinase.

David Powers, Paul Hughes, Richard Kendall, 2007, Journal of medicinal chemistry.